Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
BCG-hervaccinatie beschermt niet tegen persisterende M. tuberculosis-infectie
sep 2025 | Tuberculose, Vaccinatie